2020. Biological evaluation of 2,3-dioxoindolin-N-phenylacetamide derivatives as potent CDC25B and PTP1B phosphatase inhibitors. Brazilian Journal of Pharmaceutical Sciences. 56, (Dec. 2020), e00222. DOI:https://doi.org/10.1590/s2175-97902019000400222.